Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026
Matías J Alet, Member of Education Committee of World Stroke Organization, shared on LinkedIn:
”I was honored to participate in ESOC 2026 in Maastricht as part of the industry-sponsored satellite symposium ‘Opportunities for improving AIS patient outcomes’.
My talk, ‘Switching to TNK: the real-world experience’, focused on the implementation of tenecteplase for acute ischemic stroke, including international real-world evidence and early lessons from Argentina.
This transition is an opportunity to revisit hyperacute stroke workflows: simplifying administration, reducing treatment delays, improving transfer logistics, and strengthening local quality monitoring.
I am grateful to Boehringer Ingelheim for the invitation.
It was a privilege to share the Argentine perspective in such an important international forum.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy